MedTrace Logo

Cognitive-functional Evaluation of Anosognosia

NCT03712839 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2023-05-10

No results posted yet for this study

Summary

Acquired brain damage patients usually show severe cognitive deficit that alter their performance on every day life activities. Some of them suffer anosognosia and they are not aware of their own limitations. This situation increases disability by producing a large number of unsafe behaviours, caregivers burn-out and impede rehabilitation by affecting patients desire to follow treatment instructions. From disciplines like Neuropsychology, Cognitive Neuroscience or Occupational Therapy, it is considered a crucial issue to investigate the cognitive and neural mechanisms responsible of anosognosia, as well as to increase our knowledge about the most efficient treatments to deal with this phenomenon. The main general objective of this project is to generate and validate a detailed cognitive assessment protocol within the context of ADL to evaluate the different cognitive components of consciousness proposed on the Toglia and Kirk´s model: 1) Offline componente: metacognitive knowledge and 2) Online component: emergent awareness, self-regulation, anticipatory awareness, self-evaluation and updating processes).

Conditions

  • Anosognosia
  • Brain Damage

Interventions

OTHER

Cognitive-functional evaluation

The participants will be evaluated with a set of tools within the context of meaningful ADL.

Sponsors & Collaborators

  • Universidad de Granada

    collaborator OTHER

  • María Rodríguez Bailón

    lead OTHER

Principal Investigators

  • María Jesús Funes-Molina, Professor · Facultad de Psicología (Departamento de Psicología Experimental) - Campus de Cartuja s/n, Granada, 18071

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-18
Primary Completion
2020-03-31
Completion
2022-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03712839 on ClinicalTrials.gov